Nasreen Noor Gene Peir Asdís Finnsdottir Wagner Jay Rilinger Jenna Miller

Abstract

We describe the natural history of a three-month-old patient with Hunter Syndrome with hematopoietic stem cell transplant (HSCT) who developed recurrent diffuse alveolar hemorrhage (DAH) requiring extracorporeal membrane oxygenation (ECMO). The patient underwent HSCT with several complications, including veno-occlusive disease and DAH. He was managed with ECMO. Unfortunately, despite initial success he developed recurrent DAH and ultimately died. This is a novel report of this severe adverse event requiring ECMO following the use of HSCT in this rare patient population. We share the clinical strategies employed to address the complications associated with HSCT and the progression of his disease over his hospitalization.

##plugins.themes.bootstrap3.article.details##

Keywords

diffuse alveolar hemorrhage (DAH), extra corporal membrane oxygenation (ECMO), Hunters syndrome, bone marrow transplant, pulmonary hemorrhage

References
1. Kubaski F, Yabe H, Suzuki Y, et al. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II. Biol Blood Marrow Transplant. 2017 Oct;23(10):1795-1803. doi: 10.1016/j.bbmt.2017.06.020. PMID: 28673849; PMCID: PMC5659208.
2. Peters C, Steward CG; National Marrow Donor Program; International Bone Marrow Transplant Registry; Working Party on Inborn Errors, European Bone Marrow Transplant Group. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant. 2003 Feb;31(4):229-39. doi: 10.1038/sj.bmt.1703839. PMID: 12621457.
3. Guffon N, Bertrand Y, Forest I, Fouilhoux A, Froissart R. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J Pediatr. 2009 May;154(5):733-7. doi: 10.1016/j.jpeds.2008.11.041. PMID: 19167723.
4. Barth AL, Horovitz DDG. Hematopoietic Stem Cell Transplantation in Mucopolysaccharidosis Type II: A Literature Review and Critical Analysis. Journal of Inborn Errors of Metabolism and Screening. 2018;6. doi:10.1177/2326409818779097
5. Fan K, McArthur J, Morrison RR, Ghafoor S. Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Stem Cell Transplantation. Front Oncol. 2020 Sep 9;10:1757. doi: 10.3389/fonc.2020.01757. PMID: 33014865; PMCID: PMC7509147.
6. Vobruba V, Grus T, Mlejnsky F, et al. Management of severe pulmonary hemorrhage in a neonate on veno-arterial ECMO by the temporary clamping of the endotracheal tube - a case report. Perfusion. 2018 Jan;33(1):77-80. doi: 10.1177/0267659117723453. PMID: 28816096.
7. Biswas A, Shrestha P. Hunter's syndrome presenting as heart failure: A case report. Intl J Case Rep Imag 2013;4(6):321–325.
8. Di Nardo M, Ahmad AH, Merli P, et al. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2022 Feb;6(2):116-128. doi: 10.1016/S2352-4642(21)00336-9. PMID: 34895512; PMCID: PMC9372796.
How to Cite
Noor, N., Peir, G., Finnsdottir Wagner, A., Rilinger, J., & Miller, J. (2024). Recurrent diffuse alveolar hemorrhage and extracorporeal membrane oxygenation utilization in a hematopoietic stem cell transplant patient with Hunters syndrome. Archive of Clinical Cases, 11(1), 19-21. https://doi.org/10.22551/2024.42.1101.10281
Section
Case Reports

How to Cite

Noor, N., Peir, G., Finnsdottir Wagner, A., Rilinger, J., & Miller, J. (2024). Recurrent diffuse alveolar hemorrhage and extracorporeal membrane oxygenation utilization in a hematopoietic stem cell transplant patient with Hunters syndrome. Archive of Clinical Cases, 11(1), 19-21. https://doi.org/10.22551/2024.42.1101.10281